Mary L. Disis

Mary L. "Nora" Disis is an American physician-oncologist and the editor in chief of JAMA Oncology.

She was part of the scientific team who discovered that the HER2/neu molecule is a tumor-specific marker, or antigen.

Disis is an oncologist[1] and the director of the University of Washington's Cancer Vaccine Institute, Center for Translational Medicine in Women's Health and its Institute of Translational Health Science.

[2] She is the associate dean of the University of Washington's School of Medicine, the dean of Research and Graduate Education, the associate dean of Translational Science, the Helen B. Slonaker Endowed Professor for Cancer Research, a professor of Medicine and Oncology, and an adjunct professor of Obstetrics & Gynecology and Pathology.

[4] She was part of the investigative team who discovered that the HER2/neu molecule is a tumor-specific marker, or antigen.